Hepatic capsular retraction was observed in a benign focal liver lesion in the medical literature for the first time
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Focal nodular hyperplasia (FNH) is the second most common benign tumor of the liver and constitutes 4% of all primary hepatic tumors in pediatric population.
📊
Temel Bulgular & Veri:Here we describe the natural course of a giant hepatic FNH, which was followed up from childhood to adulthood for 12 years using computed tomography (CT) imaging and liver enzyme tests (LET).
💡
Sonuç & Katkı:Hepatic capsular retraction was observed in a benign focal liver lesion in the medical literature for the first time
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Focal nodular hyperplasia (FNH) is the second most common benign tumor of the liver and constitutes 4% of all primary hepatic tumors in pediatric population. Imaging characteristics of FNH in adults are well known, but those in children have rarely been reported. Here we describe the natural course of a giant hepatic FNH, which was followed up from childhood to adulthood for 12 years using computed tomography (CT) imaging and liver enzyme tests (LET). Differences in CT imaging characteristics were demonstrated. Changes were found in the FNH size in CT images and they were correlated with LET findings. The regression of FNH in our case was compared with the findings in the literature. Hepatic capsular retraction was observed in a benign focal liver lesion in the medical literature for the first time
🔖
Bu Makaleye Atıf Yap
GÜRSES, C., OKŞAR, F. S., EROL, B., YALÇIN, M., KAHVECİOĞLU, N., ALPARSLAN, A. Ş. (2017). Natural course of hepatic focal nodular hyperplasia from childhood to adulthood and review of the literature. Turkish Journal of Gastroenterology, Cilt: 28 - Sayı: 6, 492–497. https://ajindex.com/articles/410712
Bonney GK, Gomez D, Al-Mukhtar A, Toogood GJ, Lodge JP, Prasad R. Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB 2007; 9: 368-72
Kuo YH, Wang JH, Lu SN, et al. Natural course of hepatic focal nodular hyperplasia: A long-term follow-up study with sonography. J Clin Ultrasound 2009; 37: 132-7
Di Stasi M, Caturelli E, De Sio I, Salmi A, Buscarini E, Buscarini L. Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin Ultrasound 1996; 24: 345-50
Mathieu D, Kobeiter H, Maison P, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000; 118: 560-4
Leconte I, Van Beers BE, Lacrosse M, et al. Focal nodular hyperplasia: natural course observed with CT and MRI. J Comput Assist Tomogr 2000; 24: 61-6
Halankar JA, Kim TK, Jang HJ, Khalili K, Masoom HA. Understanding the natural history of focal nodular hyperplasia in the liver with MRI. Indian J Radiol Imaging 2012; 22: 116-20
Wang K, Lin B. Pathophysiological signifcance of hepatic apoptosis. Hepatology 2012; 2013: 740149
Kroemer G, Galluzzi L, Vandenabeele P, et al. Classification of cell death: recommendation of the nomenclature committee on cell death 2009. Cell Death Diffe. 2009; 16: 3-11.